Characterization of AmnioExcel Plus in Two Treatment Paradigms

Status Completed

Clinical Trial Summary

The Investigators plan to evaluate healing in two cohorts of patients with diabetic foot wounds (n=20) that receive optimal treatment including serial wound debridement and off-loading with a boot or postop shoe and AmnioEXCEL+. In one cohort, AmnioEXCEL+ will be applied weekly at study visits and in the second cohort, AmnioEXCEL+ will be applied maximum every 2 weeks (PRN, in the case that the wound requires debridement at a visit not intended for AE+ application, the wound will be treated as SOC). In addition, the Investigators will collect data on other potential confounding factors that could affect healing such as antibiotic, anti-fungal and anti-infective medications, tobacco, comorbidities, diabetes control, infection, perfusion, and activity. Wound healing, including wound size and adverse events will be evaluated.

Clinical Trial Description

Study Procedures: Collection of Demographic data, medical/social history Collection of medications1 Ankle Brachial Index2 Wound debridement3 (standard of care procedure) Imaging with eKare4 Hyperspectral Imaging Application of study product 1. Only collect antibiotics, anti-fungal and anti-infective medications. 2. ABI (with toe pressure) can be done at screening or baseline. 3. Once wound is healed, wound debridement will not be done at weekly visits. 4. Once wound is healed, eKare will not be done at weekly visits. 5. EOS will occur on the date the subject is healed. *Screening and Visit 1 may be done on the same day. Screening and Enrollment*: - Review and sign the Informed Consent and HIPAA Authorization - Review the inclusion and exclusion criteria If the subject qualifies for the study, they will participate in the following procedures (weekly visits, +/-4 days): Visit 1*: - Demographics (such as age, gender, race or ethnicity) - Past Medical History, Social History, Medications documented. - Labs documented as SOC within 6mo of initial visit - ABI with toe pressures2 - Wound debridement - eKare wound measurement - Hyperspectral Imaging - Randomization - Application of AmnioEXCEL+ - Source documentation - Stipend disbursement Visits 2 through 6: - Wound debridement3 - eKare wound measurement4 - Hyperspectral imaging - Application of AmnioEXCEL+ per cohort assignment - Source documentation - Stipend disbursement Visit 7: - Medications documented - Wound debridement3 - eKare wound measurement4 - Hyperspectral imaging - Application of AmnioEXCEL+ per cohort assignment - Source documentation - Stipend disbursement Visits 8-11: - Wound debridement3 - eKare wound measurement4 - Hyperspectral Imaging - Application of AmnioEXCEL+ per cohort assignment - Source documentation - Stipend disbursement Visit 12: - Wound debridement3 - eKare wound measurement4 - Source documentation - Stipend disbursement End of Study (EOS) Visit 5: - Medications documented - Wound debridement3 - eKare wound measurement4 - Source documentation - Subject exit from study ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04233580
Study type	Interventional
Source	University of Texas Southwestern Medical Center
Contact
Status	Completed
Phase	N/A
Start date	July 9, 2020
Completion date	April 6, 2021

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04497805` - Clinical Study of ALLO-ASC-SHEET in Subjects With Diabetic Wagner Grade II Foot Ulcers	Phase 2
Withdrawn	`NCT03675269` - Adjunctive Hyperbaric Oxygen Therapy (HBOT) for Lower Extermity Diabetic Ulcer:	N/A
Completed	`NCT04624516` - Effect of Self-foot Exercise on the Incidence of Plantar Foot Diabetic Ulcer Recurrence	N/A
Not yet recruiting	`NCT06439667` - VIRTUALLY SUPERVISED TELE-EXERCISE PLATFORM FOR ACCELERATING PLANTAR WOUND HEALING
Recruiting	`NCT05608187` - Evaluating Safety and Biological Effect on Wound Healing of ILP100-Topical in Subjects With Diabetic Foot Ulcers	Phase 2
Not yet recruiting	`NCT06437028` - Evaluating the Efficacy of Perinatal Membrane Allografts for the Treatment of Diabetic Foot Ulcers.	N/A
Not yet recruiting	`NCT06278935` - Lifestyle Tailored Offloading for Diabetic Foot Ulcers	N/A
Withdrawn	`NCT05024656` - AmnioExcel® Plus vs SOC in the Management of Diabetic Foot Ulcers	N/A
Terminated	`NCT02202668` - Transcutaneous Raman Spectroscope (TRS) Analyses of Diabetic Foot Ulcers	N/A
Terminated	`NCT01966380` - Proof of Concept (Design Validation) in Patient With Hard to Heal Wounds Such as Pressure Ulcer, Diabetic Foot Ulcer and Leg Ulcer, Leia	Phase 2
Completed	`NCT01951768` - Efficacy and Safety of Garamycin® Sponge in Diabetic Patients With a Moderate or Severe Foot Ulcer Infection	Phase 4
Completed	`NCT01657474` - Comparative Study of Two Application Regimens of Amniotic Membrane Wound Graft In the Management of Diabetic Foot Ulcers	N/A
Active, not recruiting	`NCT00389636` - TheraGauze™ Alone and Regranex®Gel 0.01% Plus TheraGauze™ in the Treatment of Wagner Stage I Diabetic Foot Ulcers	N/A
Completed	`NCT01181440` - Dermagraft(R) for the Treatment of Patients With Diabetic Foot Ulcers	Phase 3
Enrolling by invitation	`NCT05888259` - Plantar Pressure Distribution in Diabetic Foot Ulcer	N/A
Completed	`NCT04054804` - Digital Foot Check by Using the D-Foot, a New Software
Not yet recruiting	`NCT05877378` - Efficacy of PICO Single-use System in Chronic Ulcers	N/A
Recruiting	`NCT06037369` - The Short Message-based Customized Standardized	N/A
Completed	`NCT03312595` - Clinical Outcomes After Treatment With RestrataTM Wound Matrix in Diabetic Foot Ulcers (DFU)	N/A
Recruiting	`NCT04564443` - A Unique Micro Water Jet Technology Device Versus Standard Debridement in the Treatment of Diabetic Foot	N/A